Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Cell Biology
Biomolecules
Biomolecules
DAPK Substrate Peptide (trifluoroacetate salt)
Supplier Images
DAPK Substrate Peptide (trifluoroacetate salt)
DAPK Substrate Peptide (trifluoroacetate salt)
DAPK Substrate Peptide (trifluoroacetate salt) from Cayman Chemical
Be the first to write a review!
Supplier Page
Supplier Page from
Cayman Chemical for
DAPK Substrate Peptide (trifluoroacetate salt)
Request Info
Description
A DAPK1 peptide substrate; has been used as a target substrate for the quantification of DAPK1 activity
Product Specs
Company Info
Reviews
Product Specs
Item
DAPK Substrate Peptide (trifluoroacetate salt)
Company
Cayman Chemical
Price
$660.00
Supplier Page
View Company Product Page
Catalog Number
35221
Format
A solid
Research Area
Apoptosis, Cancer, Cell Death
Molecular Weight
1578.8204
Size
10 mg
Purity
≥98%
Storage
-20
Formula
C70H115N25O17 • XCF3COOH
Origin
CHN
Add to Compare List
Cayman Chemical
Cayman Chemical Company 1180 East Ellsworth Road
Ann Arbor
,
Michigan
48108
United States
Phone
: (800) 364-9897
(734) 971-3640
Company Profile
Website:
http://www.caymanchem.com/
Reviews
Be the First to Write a Review!
DAPK Substrate Peptide (trifluoroacetate salt) from Cayman Chemical
Supplier Page
View Company Product Page
$660.00
Product Specs
Company Info
Reviews
Back To Top